Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN, USA.
Br J Pharmacol. 2019 Jun;176(12):2015-2027. doi: 10.1111/bph.14364. Epub 2018 Jun 21.
Monocytes play a critical role in hypertension. The purpose of our study was to use an unbiased approach to determine whether hypertensive individuals on conventional therapy exhibit an altered monocyte gene expression profile and to perform validation studies of selected genes to identify novel therapeutic targets for hypertension.
Next generation RNA sequencing identified differentially expressed genes in a small discovery cohort of normotensive and hypertensive individuals. Several of these genes were further investigated for association with hypertension in multiple validation cohorts using qRT-PCR, regression analysis, phenome-wide association study and case-control analysis of a missense polymorphism.
We identified 60 genes that were significantly differentially expressed in hypertensive monocytes, many of which are related to IL-1β. Uni- and multivariate regression analyses of the expression of these genes with mean arterial pressure (MAP) revealed four genes that significantly correlated with MAP in normotensive and/or hypertensive individuals. Of these, lactoferrin (LTF), peptidoglycan recognition protein 1 and IL-18 receptor accessory protein (IL18RAP) remained significantly elevated in peripheral monocytes of hypertensive individuals in a separate validation cohort. Interestingly, IL18RAP expression associated with MAP in a cohort of African Americans. Furthermore, homozygosity for a missense single nucleotide polymorphism in LTF that decreases antimicrobial function and increases protein levels (rs1126478) was over-represented in patients with hypertension relative to controls (odds ratio 1.16).
These data demonstrate that monocytes exhibit enhanced pro-inflammatory gene expression in hypertensive individuals and identify IL18RAP and LTF as potential novel mediators of human hypertension.
This article is part of a themed section on Immune Targets in Hypertension. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.12/issuetoc.
单核细胞在高血压中起着关键作用。本研究的目的是采用一种无偏倚的方法来确定接受常规治疗的高血压患者是否存在单核细胞基因表达谱的改变,并对选定基因进行验证研究,以确定高血压的新治疗靶点。
下一代 RNA 测序确定了正常血压和高血压个体小发现队列中差异表达的基因。使用 qRT-PCR、回归分析、全基因组关联研究和错义多态性病例对照分析,对其中一些基因在多个验证队列中与高血压的相关性进行了进一步研究。
我们鉴定了 60 个在高血压单核细胞中差异表达显著的基因,其中许多与 IL-1β 相关。对这些基因与平均动脉压 (MAP) 的表达进行单变量和多变量回归分析,发现 4 个基因在正常血压和/或高血压个体中与 MAP 显著相关。其中,乳铁蛋白 (LTF)、肽聚糖识别蛋白 1 和白细胞介素 18 受体辅助蛋白 (IL18RAP) 在另一个验证队列中,在高血压个体的外周单核细胞中仍然显著升高。有趣的是,IL18RAP 表达与非洲裔美国人队列中的 MAP 相关。此外,LTF 中一个降低抗菌功能和增加蛋白水平的错义单核苷酸多态性(rs1126478)的纯合子在高血压患者中比对照组更常见(比值比 1.16)。
这些数据表明,高血压个体的单核细胞表现出增强的促炎基因表达,并确定 IL18RAP 和 LTF 为人类高血压的潜在新介质。
本文是免疫靶点在高血压中的专题部分的一部分。要查看本部分中的其他文章,请访问 http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.12/issuetoc.